Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies

NCT03913949

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • Anhui Procincial hospital Hefei, Anhui, China
  • Henan Provincial Oncology Hospital Zhengzhou, Henan, China
  • Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
  • Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Active, Not Recruiting

A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain

NCT06125795

Conditions
Behavior, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations
  • HUA - Txagorritxu /ID# 258263 Vitoria-Gasteiz, Alava, Spain
  • Sant Joan de Deu de Manresa /ID# 258266 Manresa, Barcelona, Spain
  • Hospital Universitari Mútua Terrassa /ID# 258267 Terrassa, Barcelona, Spain
  • Hospital Jerez De La Frontera /ID# 258282 Jerez de la Frontera, Cadiz, Spain
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

NCT06035497

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +26 more
Locations
  • Local Institution - 0031 Anjo-shi, Aichi-ken, Japan
  • Local Institution - 0011 Nagoya, Aichi-ken, Japan
  • Local Institution - 0024 Toyohashi, Aichi-ken, Japan
  • Local Institution - 0017 Kamogawa, Chiba, Japan
View all 40 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

NCT06752850

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Classic Hemophilia, +24 more
Locations
  • Sobi Investigational Site Milan, Italy
  • Sobi Investigational Site Naples, Italy
  • Sobi Investigational Site Rozzano, Italy
  • Sobi Investigational Site Oslo, Norway
View Trial Details
Active, Not Recruiting

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients

NCT05014646

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Atrium Health University City/LCI-University Charlotte, North Carolina, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

NCT05133531

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • The Oncology Institute of Hope & Innovation Whittier, California, United States
  • Centro de Estudos e Pesquisas em Hematologia e Oncologia Santo André, São Paulo, Brazil
  • A Beneficencia Portuguesa de Sao Paulo, BP Mirante São Paulo, Brazil
  • Casa de Saude Santa Marcelina São Paulo, Brazil
View all 68 locations
View Trial Details
Active, Not Recruiting

A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)

NCT05347225

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations
  • Guangdong Provincial People's Hospital-hematology department ( Site 1002) Guangzhou, Guangdong, China
  • SUN YAT-SEN UNIVERSITY CANCER CENTRE-Internal medicine ( Site 1007) Guangzhou, Guangdong, China
  • Henan Cancer Hospital-hematology department ( Site 1003) Zhengzhou, Henan, China
  • Hunan Cancer Hospital ( Site 1004) Changsha, Hunan, China
View Trial Details

Related conditions